| 2022 | | Adverse Events and Safety of Oral Cyclosporine for Dermatoses among Children and Adolescents: A Single Center Study | 강희영, 박영준, 최지웅 |
| 2015 | | Application and Developmental Strategies for Community-Based Injury Prevention Programs of the International Safe Communities Movement in Korea. | 조준필 |
| 2014 | | Clinical Usefulness of Fentanyl Matrix Patch for the Patients with Chronic Low Back Pain | 전창훈, 정남수 |
| 2023 | | Comparative effectiveness of JAK inhibitors and biologic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis | 김현아 |
| 2024 | | Comparative estimation of the effects of antihypertensive medications on schizophrenia occurrence: a multinational observational cohort study | 박래웅, 손상준 |
| 2024 | | Comparative safety analysis of mRNA and adenoviral vector COVID-19 vaccines: a nationwide cohort study using an emulated target trial approach | 현학준 |
| 2018 | | Complications following ultrasound-guided core needle biopsy of thyroid nodules: a systematic review and meta-analysis | 하은주 |
| 1997 | | Direct endovascular thrombolytic therapy for dural sinus thrombosis: infusion of alteplase. | 김선용, 서정호 |
| 2008 | | Double-blind, Randomized, Multi-center, Comparative Clinical Trial of Sibutramine Mesilate with Sibutramine Hydrochloride for Evaluating Efficacy and Safety in Obese Patients | 김범택, 이관우 |
| 2005 | | Effect of Community Based Child Safety Education Program for Child Care Teachers | 방경숙 |
| 2018 | | Effect of Growth Hormone Therapy on Height Velocity in Korean Children with Idiopathic Short Stature: A Phase III Randomised Controlled Trial | 황진순 |
| 2005 | | Effect of Safety Education for Mothers with Infants | 방경숙 |
| 1999 | | Efficacy and Safety of Glimepiride: A Novel Sulfonylurea Drug Compared with Gliclazide in the Treatment of Type 2 Diabetes Mellitus: an Open, Randomized Comparative Multi-Center Clinical Study | 이관우 |
| 2020 | | Efficacy and Safety of Rituximab in Korean Patients with Refractory Inflammatory Myopathies | 서창희 |
| 2023 | | Immunogenicity and safety of SARS-CoV-2 recombinant protein nanoparticle vaccine GBP510 adjuvanted with AS03: interim results of a randomised, active-controlled, observer-blinded, phase 3 trial | 김은진, 허중연 |
| 2014 | | Implementation and Results of a Survey on Safe Community Programs in Gangbuk-gu, Korea: Focusing on Participants at a Local Public Health Center | 조준필 |
| 2014 | | Oral immunotherapy for the treatment of immediate type food allergy | 이수영 |
| 2021 | | Rapid symptom improvement in major depressive disorder using accelerated repetitive transcranial magnetic stimulation | 노재성, 손상준 |
| 2012 | | Roles of a hospital for community safety promotion | 이정아, 조준필 |
| 2019 | | Safety and Effectiveness Analysis of Kivexa(R) (lamivudine/abacavir sulfate) in Human Immunodeficiency Virus Infected Korean Patients | 최영화 |
| 2023 | | Safety and Effectiveness of Etanercept Biosimilar SB4 for Rheumatic Diseases in South Korea: Real-World Post-marketing Surveillance Data | 서창희 |
| 2022 | | Safety and efficacy of clonazepam in patients with hemifacial spasm: A double-blind, randomized, placebo-controlled trial | 손성연 |
| 2014 | | Safety and efficacy of conversion from twice-daily tacrolimus to once-daily tacrolimus one month after transplantation: randomized controlled trial in adult renal transplantation. | 오창권 |
| 2023 | | Safety and Immunogenicity of the ID93 + GLA-SE Tuberculosis Vaccine in BCG-Vaccinated Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial | 박광주 |
| 2013 | | Safety and Reactogenicity of the Inactivated Poliomyelitis Vaccine (PoliorixTM) in Korea (2006-2012) | 박문성 |
| 2018 | | Safety and tolerability of Korean Red Ginseng in healthy adults: a multicenter, double-blind, randomized, placebo-controlled trial | 김광민 |
| 2024 | | Safety outcomes of antipsychotics classes in drug-naïve patients with first-episode schizophrenia: A nationwide cohort study in South Korea | 박래웅 |
| 2023 | | The third dose of measles-containing vaccine induces robust immune responses against measles in young seronegative healthcare workers who had previous two-dose measles vaccination | 최영화 |
| 2023 | | Three-Year Safety, Tolerability, and Health-Related Quality of Life Outcomes of Adjuvant Osimertinib in Patients With Resected Stage IB to IIIA EGFR-Mutated NSCLC: Updated Analysis From the Phase 3 ADAURA Trial | 최진혁 |
